<DOC>
	<DOC>NCT02989610</DOC>
	<brief_summary>The purpose of this post market study is to support the chronic clinical performance of the Infinity Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG), DBS leads, extensions and related system components.</brief_summary>
	<brief_title>Clinical Evaluation of the Infinity DBS System</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Subject is able to provide informed consent; Subjects diagnosed with Parkinson's disease (PD) and have been recommended to receive a DBS implant in the Subthalamic Nucleus (STN) or that have been implanted with an Infinity system in the STN; Subject must be available for followup visits. Subject is not a surgical candidate; In the Investigator's opinion the subject is unable to tolerate multiple programming sessions within a single setting; Subject is unable to comply with the follow up schedule.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>